查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2111202

空間體學市場預測至2034年－全球分析（按體學類型、工作流程、產品類型、樣本類型、軟體部署、技術、應用、最終用戶和地區分類）

Spatial Omics Market Forecasts To 2034 - Global Analysis By Omics Type, Workflow, Product, Sample Type, Software Deployment, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球空間體學市場規模將達到 9.8 億美元，在預測期內將以 17.4% 的複合年成長率成長，到 2034 年將達到 35.363 億美元。

空間體學市場專注於先進技術，這些技術能夠分析基因、蛋白質和其他生物分子，同時保持組織和細胞內精確的位置資訊。透過將分子分析與空間資訊結合，這些解決方案能夠全面了解細胞功能、組織結構和疾病的生物學機制。空間體學在腫瘤學、神經科學、免疫學和藥物研究中發揮著至關重要的作用，它能夠識別精確的生物標記並支持精準醫療。影像系統、定序技術、多重檢測和計算分析的持續創新正在推動學術機構、生物技術公司、製藥公司和臨床研究機構對空間組學的進一步應用。

增加製藥和生技領域的研發投資

製藥和生物技術領域研發投入的增加顯著推動了太空體學市場的成長。開發創新療法的公司需要先進的分析工具來深入了解疾病的生物機制並檢驗潛在的藥物標靶。空間體學能夠提供完整組織內的全面分子訊息，從而增強生物標記發現和治療評估的信心。生命科學研究經費的增加、產學夥伴關係的加強以及臨床開發計畫的增多，都在推動空間組學的應用。這些投入正在強化空間體學在加速藥物發現和轉化生物醫學研究中的作用。

空間體學設備和耗材高成本

空間體學技術所需的巨額投資限制了其市場普及。昂貴的分析儀器、成像平台、定序系統和專用試劑給許多學術研究機構、生物技術新創公司和醫療機構帶來了巨大的經濟負擔。維護合約、軟體許可和實驗室耗材等持續性成本進一步增加了整體營運成本。預算限制常常阻礙機構（尤其是在新興經濟體）升級到先進的太空生物學平台。因此，許多研究中心仍沿用傳統的分子分析方法，儘管空間體學具有顯著的科學和臨床價值，但其廣泛應用仍受到阻礙。

拓展空間體學在臨床診斷的應用

空間體學在臨床診斷的應用日益廣泛，展現出巨大的市場成長潛力。醫療機構正在採用先進的分子分析工具，這些工具能夠在保持組織完整性的同時提供特異性位置的生物學資訊。這些技術能夠提高診斷準確性，支持生物標記的驗證，並有助於制定以患者為中心的最佳化治療方案。隨著臨床檢驗研究的不斷深入和技術的進步，醫院和診斷實驗室正在推進空間體學在常規醫療應用中的評估。隨著法律規範的日益清晰和檢查室工作流程的不斷最佳化，預計空間組學在臨床環境中的更廣泛應用將為技術提供者和醫療機構創造長期的商業機會。

經濟放緩導致研究經費減少

景氣衰退和預算限制可能會對空間體學市場的成長產生負面影響，因為這會限制對科學研究和實驗室現代化的資金支持。政府、大學、生技公司和製藥公司可能會優先考慮必要的支出，而推遲對昂貴研究技術的投資。資金減少可能會導致設備採購延遲、合作項目延期，並限制先進分子研究項目的擴展。由於空間體學平台需要高額的資本投資，因此它們對經濟不確定性特別敏感。長期的財政壓力可能導致市場需求下降、創新放緩，並影響產業的長期發展。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對空間體學市場產生了影響，既帶來了短期衝擊，也帶來了長期成長機會。疫情初期，實驗室面臨營運限制、設備交付延遲和科學研究專案延期等問題，導致技術應用暫時下降。然而，全球對病毒感染和免疫系統行為的關注，使得對先進分子研究工具的需求顯著成長。空間體學因其分析組織特異性生物反應的能力而獲得廣泛認可，為感染疾病研究、生物標記發現和治療研究提供了支持。隨著科學研究活動的復甦，生命科學和精準醫學領域的投資加速了學術界、製藥界和臨床研究領域的市場擴張。

在預測期內，轉錄組學領域預計將佔據最大的市場規模。

預計在預測期內，轉錄組學領域將佔據最大的市場佔有率，因為它能夠在保留組織自然空間結構的同時，提供關於基因表現的全面洞察。這項能力使科學家能夠以極高的精度研究細胞行為、組織結構和生物通路，從而支持癌症、神經科學、免疫學和再生醫學等領域的尖端研究。定序方法、成像技術和生物資訊學工具的持續創新顯著提高了工作流程效率和分析準確性。製藥公司、生物技術公司和研究機構擴大採用轉錄組學進行生物標記鑑定、藥物發現和精準醫療，這進一步鞏固了該領域在太空體學市場的主導地位。

預計在預測期內，「數位空間剖面分析」細分市場將實現最高的複合年成長率。

在預測期內，「數位空間分析」細分市場預計將呈現最高的成長率，這主要得益於其能夠在保持生物組織精確空間資訊的同時，提供高度多層次的分子分析。研究人員正日益依賴這項技術，以極高的精度研究複雜的細胞間相互作用、蛋白質表現和RNA分佈。其在癌症研究、免疫分析、治療藥物開發和精準醫療等領域的廣泛應用，正在推動市場需求的成長。自動化、高通量分析、成像能力和運算工具的不斷改進，使得這些平台更有效率且方便。生技公司、製藥公司和學術研究機構的持續投資，也為空間體學市場中這一細分市場的快速成長提供了有力支撐。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其成熟的生命科學生態系統、強大的研究能力以及對精準醫療的高度重視。該地區聚集了許多生物技術公司、製藥企業和學術研究中心，這些機構廣泛利用空間體學技術進行疾病研究和藥物研發。來自公共和私營部門的持續投入，加上先進的實驗室基礎設施和不斷創新，正在推動這項技術的廣泛應用。策略合作、生物標記研究活動的活性化以及先進分子分析工具的快速普及，進一步鞏固了北美在全球空間體學市場的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於生命科學研究的拓展、醫療保健投資的增加以及技術的快速發展。在政府推動精準醫療和創新措施的支持下，生物技術、藥物研發和基因組學研究在該地區正經歷強勁成長。學術機構、研究組織和生物技術公司正擴大採用空間體學平台來加強疾病研究、生物標記發現和藥物研發。實驗室基礎設施的不斷完善、國際研究合作的日益增加以及對先進分子分析技術需求的成長，都為亞太全部區域市場的持續擴張創造了有利條件。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰和機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球空間體學市場：依體學類型分類

  • 轉錄組學
  • 基因組學
  • 蛋白質體學
  • 代謝體學
  • 脂類組學
  • 多體學

第6章 全球空間體學市場：依工作流程分類

  • 樣品製備
  • 圖書館調整
  • 空間標籤和條碼
  • 數據採集
  • 數據分析與解讀
  • 可視化和報告創建

第7章 全球空間體學市場：依產品分類

  • 裝置
    • 空間定序系統
    • 空間成像系統
    • 顯微鏡系統
    • 幻燈片掃描儀
    • 自動化樣品製備系統
  • 耗材和試劑
    • 檢測試劑盒
    • 試劑
    • 幻燈片和提示
    • 條碼標籤套件
    • 抗體和探針
    • 樣品製備耗材
  • 軟體
    • 數據分析軟體
    • 影像分析軟體
    • 生物資訊平台
    • 視覺化軟體
    • 基於雲端的分析平台
  • 服務
    • 樣品處理服務
    • 定序服務
    • 影像服務
    • 生物資訊學和數據分析服務
    • 諮詢和技術支援服務

第8章：全球空間體學市場：依樣本類型分類

  • 新鮮/冷凍組織
  • 福馬林固定石蠟包埋組織
  • 細胞樣本
  • 類器官
  • 組織微陣列
  • 其他樣本類型

第9章：全球空間體學市場：依軟體部署方式分類

  • 現場
  • 基於雲端的
  • 混合

第10章：全球空間體學市場：依技術分類

  • 次世代定序
  • 原位雜合反應
  • 螢光影像
  • 成像質譜法
  • 數位空間剖面分析

第11章 全球空間體學市場：按應用分類

  • 腫瘤學
  • 神經科學
  • 免疫學
  • 發育生物學
  • 細胞生物學
  • 心血管檢查
  • 感染疾病調查
  • 再生醫學
  • 生物標記的發現
  • 藥物發現與開發
  • 精準醫療
  • 臨床診斷

第12章 全球空間體學市場：依最終使用者分類

  • 製藥和生物技術公司
  • 學術研究機構
  • 醫院和臨床檢查室
  • 受託研究機構
  • 診斷中心
  • 政府和公共衛生組織

第13章 全球空間體學市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第14章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第15章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第16章：公司簡介

  • 10x Genomics, Inc.
  • Bruker Corporation
  • NanoString Technologies, Inc.
  • Standard BioTools Inc.
  • Illumina, Inc.
  • Bio-Techne Corporation
  • Danaher Corporation
  • Akoya Biosciences, Inc.
  • Vizgen, Inc.
  • Resolve Biosciences GmbH
  • Oxford Nanopore Technologies plc
  • Pixelgen Technologies AB
  • Curio Bioscience
  • RareCyte, Inc.
  • Molecular Instruments, Inc.
  • Enable Medicine, Inc.
  • Rebus Biosystems, Inc.
  • Singular Genomics Systems, Inc.
Product Code: SMRC38889

According to Stratistics MRC, the Global Spatial Omics Market is accounted for $980.0 million in 2026 and is expected to reach $3536.3 million by 2034 growing at a CAGR of 17.4% during the forecast period. The Spatial Omics Market focuses on advanced technologies that analyze genes, proteins, and other biomolecules while maintaining their exact position within tissues and cells. By combining molecular analysis with spatial information, these solutions offer a comprehensive understanding of cellular functions, tissue structures, and disease biology. Spatial omics plays a vital role in oncology, neuroscience, immunology, and pharmaceutical research by enabling accurate biomarker identification and supporting precision medicine. Ongoing innovations in imaging systems, sequencing technologies, multiplex assays, and computational analytics continue to strengthen adoption across academic institutions, biotechnology companies, pharmaceutical organizations, and clinical research settings.

Market Dynamics:

Driver:

Increasing Pharmaceutical and Biotechnology R&D Investments

Higher spending on pharmaceutical and biotechnology research is contributing significantly to the growth of the Spatial Omics Market. Companies developing innovative therapies require sophisticated analytical tools to better understand disease biology and validate potential drug targets. Spatial omics offers comprehensive molecular insights within intact tissues, improving confidence in biomarker discovery and therapeutic evaluation. Increased financial support for life science research, expanding partnerships between industry and academic organizations, and a growing number of clinical development programs are driving adoption. These investments are strengthening the role of spatial omics in accelerating drug discovery and translational biomedical research.

Restraint:

High Cost of Spatial Omics Instruments and Consumables

The substantial investment required for spatial omics technologies restricts broader market adoption. High-priced analytical instruments, imaging platforms, sequencing systems, and specialized reagents create financial challenges for many academic laboratories, biotechnology startups, and healthcare institutions. Ongoing expenses associated with maintenance contracts, software licensing, and laboratory consumables further increase total operating costs. Budget limitations frequently prevent organizations from upgrading to advanced spatial biology platforms, especially in emerging economies. As a result, many research centers continue using established molecular analysis methods, slowing the widespread implementation of spatial omics despite its significant scientific and clinical advantages.

Opportunity:

Expansion of Spatial Omics in Clinical Diagnostics

The increasing use of spatial omics in clinical diagnostic applications offers substantial growth potential for the market. Medical institutions are adopting advanced molecular analysis tools capable of delivering location-specific biological information while maintaining tissue integrity. These technologies enhance diagnostic precision, support biomarker confirmation, and improve patient-specific therapeutic decisions. Growing clinical validation studies and technological advancements are encouraging hospitals and diagnostic laboratories to evaluate spatial omics for routine healthcare applications. As regulatory pathways become clearer and laboratory workflows become more efficient, broader clinical implementation is expected to create long-term opportunities for technology providers and healthcare organizations.

Threat:

Economic Slowdowns Reducing Research Funding

Economic downturns and budget constraints can negatively influence the growth of the Spatial Omics Market by limiting financial support for scientific research and laboratory modernization. Governments, universities, biotechnology firms, and pharmaceutical companies may prioritize essential expenditures while delaying investments in expensive research technologies. Reduced funding can slow equipment purchases, postpone collaborative projects, and limit expansion of advanced molecular research programs. Since spatial omics platforms require substantial capital investment, they are particularly sensitive to economic uncertainty. Extended financial pressures could reduce market demand, delay innovation, and affect long-term industry development.

Covid-19 Impact:

The COVID-19 outbreak influenced the Spatial Omics Market through both short-term disruptions and long-term growth opportunities. Early in the pandemic, research laboratories experienced operational restrictions, equipment delivery delays, and postponed scientific studies, temporarily reducing technology adoption. Nevertheless, the global focus on understanding viral infections and immune system behavior significantly increased demand for advanced molecular research tools. Spatial omics gained greater recognition for its ability to analyze tissue-specific biological responses, supporting infectious disease studies, biomarker discovery, and therapeutic research. Following the recovery of research operations, investments in life sciences and precision medicine accelerated market expansion across academic, pharmaceutical, and clinical research sectors.

The Transcriptomics segment is expected to be the largest during the forecast period

The Transcriptomics segment is expected to account for the largest market share during the forecast period, because it provides comprehensive insights into gene expression while maintaining the natural spatial organization of tissues. This capability allows scientists to investigate cellular behavior, tissue architecture, and biological pathways with exceptional precision, supporting advanced research across cancer, neuroscience, immunology, and regenerative medicine. Ongoing innovations in sequencing methods, imaging technologies, and bioinformatics tools have significantly improved workflow efficiency and analytical accuracy. Increasing adoption by pharmaceutical companies, biotechnology organizations, and research institutions for biomarker identification, drug development, and precision medicine continues to strengthen the segment's leadership in the spatial omics market.

The Digital Spatial profiling segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Digital Spatial Profiling segment is predicted to witness the highest growth rate, because it provides highly multiplexed molecular analysis while maintaining the precise spatial context of biological tissues. Researchers increasingly rely on this technology to investigate complex cellular interactions, protein expression, and RNA distribution with exceptional accuracy. Its expanding use in cancer research, immune profiling, therapeutic development, and precision medicine is strengthening market demand. Ongoing improvements in automation, high-throughput analysis, imaging performance, and computational tools are making these platforms more efficient and accessible. Rising investments from biotechnology companies, pharmaceutical organizations, and academic research institutions continue to support rapid growth of this segment within the spatial omics market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, owing to its well-established life sciences ecosystem, robust research capabilities, and strong emphasis on precision healthcare. The region has a high concentration of biotechnology companies, pharmaceutical manufacturers, and academic research centers that extensively utilize spatial omics technologies for disease research and drug development. Continuous financial support from public and private sectors, combined with advanced laboratory infrastructure and ongoing technological innovation, encourages widespread adoption. Strategic collaborations, increasing biomarker research activities, and rapid integration of advanced molecular analysis tools continue to reinforce North America's dominant position in the global spatial omics market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding life sciences research, increasing healthcare investments, and rapid technological advancement. The region is experiencing strong growth in biotechnology, pharmaceutical development, and genomic research, supported by government initiatives promoting precision medicine and innovation. Academic organizations, research institutes, and biotechnology companies are increasingly adopting spatial omics platforms to enhance disease research, biomarker discovery, and drug development. Continuous improvements in laboratory infrastructure, growing international research collaborations, and rising demand for advanced molecular analysis technologies are creating favorable conditions for sustained market expansion across the Asia-Pacific region.

Key players in the market

Some of the key players in Spatial Omics Market include 10x Genomics, Inc., Bruker Corporation, NanoString Technologies, Inc., Standard BioTools Inc., Illumina, Inc., Bio-Techne Corporation, Danaher Corporation, Akoya Biosciences, Inc., Vizgen, Inc., Resolve Biosciences GmbH, Oxford Nanopore Technologies plc, Pixelgen Technologies AB, Curio Bioscience, RareCyte, Inc., Molecular Instruments, Inc., Enable Medicine, Inc., Rebus Biosystems, Inc. and Singular Genomics Systems, Inc.

Key Developments:

In April 2026, Bruker Spatial Biology collaborated with the University Medical Center Schleswig-Holstein (UKSH) to showcase high-plex CellScape XR spatial proteomics datasets at AACR 2026.

In March 2026 , 10x Genomics became a key partner in STELA (Spatial Tissue Exploration and Linked Atlas), a multinational initiative led by Bioptimus in collaboration with Broad Clinical Labs. The partnership aims to create one of the world's largest clinically linked spatial biology atlases by profiling up to 100,000 patient specimens, generating foundational datasets to advance AI-driven biological research, disease understanding, and precision medicine.

Omics Types Covered:

  • Transcriptomics
  • Genomics
  • Proteomics
  • Metabolomics
  • Lipidomics
  • Multi-Omics

Workflows Covered:

  • Sample Preparation
  • Library Preparation
  • Spatial Labeling & Barcoding
  • Data Acquisition
  • Data Analysis & Interpretation
  • Visualization & Reporting

Product Covered:

  • Instruments
  • Consumables & Reagents
  • Software
  • Services

Sample Types Covered:

  • Fresh Frozen Tissue
  • Formalin-Fixed Paraffin-Embedded Tissue
  • Cell Samples
  • Organoids
  • Tissue Microarrays
  • Others Sample Types

Software Deployments Covered:

  • On-Premises
  • Cloud-Based
  • Hybrid

Technologies Covered:

  • Next-Generation Sequencing
  • In Situ Hybridization
  • Fluorescence Imaging
  • Imaging Mass Spectrometry
  • Digital Spatial Profiling

Applications Covered:

  • Oncology
  • Neuroscience
  • Immunology
  • Developmental Biology
  • Cell Biology
  • Cardiovascular Research
  • Infectious Disease Research
  • Regenerative Medicine
  • Biomarker Discovery
  • Drug Discovery & Development
  • Precision Medicine
  • Clinical Diagnostics

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Laboratories
  • Contract Research Organizations
  • Diagnostic Centers
  • Government & Public Health Organizations

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modelling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Spatial Omics Market, By Omics Type

  • 5.1 Transcriptomics
  • 5.2 Genomics
  • 5.3 Proteomics
  • 5.4 Metabolomics
  • 5.5 Lipidomics
  • 5.6 Multi-Omics

6 Global Spatial Omics Market, By Workflow

  • 6.1 Sample Preparation
  • 6.2 Library Preparation
  • 6.3 Spatial Labelling & Bar-coding
  • 6.4 Data Acquisition
  • 6.5 Data Analysis & Interpretation
  • 6.6 Visualization & Reporting

7 Global Spatial Omics Market, By Product

  • 7.1 Instruments
    • 7.1.1 Spatial Sequencing Systems
    • 7.1.2 Spatial Imaging Systems
    • 7.1.3 Microscopy Systems
    • 7.1.4 Slide Scanners
    • 7.1.5 Automated Sample Preparation Systems
  • 7.2 Consumables & Reagents
    • 7.2.1 Assay Kits
    • 7.2.2 Reagents
    • 7.2.3 Slides & Chips
    • 7.2.4 Bar-coding & Labelling Kits
    • 7.2.5 Antibodies & Probes
    • 7.2.6 Sample Preparation Consumables
  • 7.3 Software
    • 7.3.1 Data Analysis Software
    • 7.3.2 Image Analysis Software
    • 7.3.3 Bioinformatics Platforms
    • 7.3.4 Visualization Software
    • 7.3.5 Cloud-Based Analytics Platforms
  • 7.4 Services
    • 7.4.1 Sample Processing Services
    • 7.4.2 Sequencing Services
    • 7.4.3 Imaging Services
    • 7.4.4 Bioinformatics & Data Analysis Services
    • 7.4.5 Consulting & Technical Support Services

8 Global Spatial Omics Market, By Sample Type

  • 8.1 Fresh Frozen Tissue
  • 8.2 Formalin-Fixed Paraffin-Embedded Tissue
  • 8.3 Cell Samples
  • 8.4 Organoids
  • 8.5 Tissue Microarrays
  • 8.6 Others Sample Types

9 Global Spatial Omics Market, By Software Deployment

  • 9.1 On-Premises
  • 9.2 Clouds-Based
  • 9.3 Hybrid

10 Global Spatial Omics Market, By Technology

  • 10.1 Next-Generation Sequencing
  • 10.2 In Situ Hybridization
  • 10.3 Fluorescence Imaging
  • 10.4 Imaging Mass Spectrometry
  • 10.5 Digital Spatial Profiling

11 Global Spatial Omics Market, By Application

  • 11.1 Oncology
  • 11.2 Neuroscience
  • 11.3 Immunology
  • 11.4 Developmental Biology
  • 11.5 Cell Biology
  • 11.6 Cardiovascular Research
  • 11.7 Infectious Disease Research
  • 11.8 Regenerative Medicine
  • 11.9 Biomarker Discovery
  • 11.10 Drug Discovery & Development
  • 11.11 Precision Medicine
  • 11.12 Clinical Diagnostics

12 Global Spatial Omics Market, By End User

  • 12.1 Pharmaceutical & Biotechnology Companies
  • 12.2 Academic & Research Institutes
  • 12.3 Hospitals & Clinical Laboratories
  • 12.4 Contract Research Organizations
  • 12.5 Diagnostic Centers
  • 12.6 Government & Public Health Organizations

13 Global Spatial Omics Market, By Geography

  • 13.1 North America
    • 13.1.1 United States
    • 13.1.2 Canada
    • 13.1.3 Mexico
  • 13.2 Europe
    • 13.2.1 United Kingdom
    • 13.2.2 Germany
    • 13.2.3 France
    • 13.2.4 Italy
    • 13.2.5 Spain
    • 13.2.6 Netherlands
    • 13.2.7 Belgium
    • 13.2.8 Sweden
    • 13.2.9 Switzerland
    • 13.2.10 Poland
    • 13.2.11 Rest of Europe
  • 13.3 Asia Pacific
    • 13.3.1 China
    • 13.3.2 Japan
    • 13.3.3 India
    • 13.3.4 South Korea
    • 13.3.5 Australia
    • 13.3.6 Indonesia
    • 13.3.7 Thailand
    • 13.3.8 Malaysia
    • 13.3.9 Singapore
    • 13.3.10 Vietnam
    • 13.3.11 Rest of Asia Pacific
  • 13.4 South America
    • 13.4.1 Brazil
    • 13.4.2 Argentina
    • 13.4.3 Colombia
    • 13.4.4 Chile
    • 13.4.5 Peru
    • 13.4.6 Rest of South America
  • 13.5 Rest of the World (RoW)
    • 13.5.1 Middle East
      • 13.5.1.1 Saudi Arabia
      • 13.5.1.2 United Arab Emirates
      • 13.5.1.3 Qatar
      • 13.5.1.4 Israel
      • 13.5.1.5 Rest of Middle East
    • 13.5.2 Africa
      • 13.5.2.1 South Africa
      • 13.5.2.2 Egypt
      • 13.5.2.3 Morocco
      • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

  • 14.1 Industry Value Network and Supply Chain Assessment
  • 14.2 White-Space and Opportunity Mapping
  • 14.3 Product Evolution and Market Life Cycle Analysis
  • 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

  • 15.1 Mergers and Acquisitions
  • 15.2 Partnerships, Alliances, and Joint Ventures
  • 15.3 New Product Launches and Certifications
  • 15.4 Capacity Expansion and Investments
  • 15.5 Other Strategic Initiatives

16 Company Profiles

  • 16.1 10x Genomics, Inc.
  • 16.2 Bruker Corporation
  • 16.3 NanoString Technologies, Inc.
  • 16.4 Standard BioTools Inc.
  • 16.5 Illumina, Inc.
  • 16.6 Bio-Techne Corporation
  • 16.7 Danaher Corporation
  • 16.8 Akoya Biosciences, Inc.
  • 16.9 Vizgen, Inc.
  • 16.10 Resolve Biosciences GmbH
  • 16.11 Oxford Nanopore Technologies plc
  • 16.12 Pixelgen Technologies AB
  • 16.13 Curio Bioscience
  • 16.14 RareCyte, Inc.
  • 16.15 Molecular Instruments, Inc.
  • 16.16 Enable Medicine, Inc.
  • 16.17 Rebus Biosystems, Inc.
  • 16.18 Singular Genomics Systems, Inc.

List of Tables

  • Table 1 Global Spatial Omics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Spatial Omics Market Outlook, By Omics Type (2023-2034) ($MN)
  • Table 3 Global Spatial Omics Market Outlook, By Transcriptomics (2023-2034) ($MN)
  • Table 4 Global Spatial Omics Market Outlook, By Genomics (2023-2034) ($MN)
  • Table 5 Global Spatial Omics Market Outlook, By Proteomics (2023-2034) ($MN)
  • Table 6 Global Spatial Omics Market Outlook, By Metabolomics (2023-2034) ($MN)
  • Table 7 Global Spatial Omics Market Outlook, By Lipidomics (2023-2034) ($MN)
  • Table 8 Global Spatial Omics Market Outlook, By Multi-Omics (2023-2034) ($MN)
  • Table 9 Global Spatial Omics Market Outlook, By Workflow (2023-2034) ($MN)
  • Table 10 Global Spatial Omics Market Outlook, By Sample Preparation (2023-2034) ($MN)
  • Table 11 Global Spatial Omics Market Outlook, By Library Preparation (2023-2034) ($MN)
  • Table 12 Global Spatial Omics Market Outlook, By Spatial Labelling & Bar-coding (2023-2034) ($MN)
  • Table 13 Global Spatial Omics Market Outlook, By Data Acquisition (2023-2034) ($MN)
  • Table 14 Global Spatial Omics Market Outlook, By Data Analysis & Interpretation (2023-2034) ($MN)
  • Table 15 Global Spatial Omics Market Outlook, By Visualization & Reporting (2023-2034) ($MN)
  • Table 16 Global Spatial Omics Market Outlook, By Product (2023-2034) ($MN)
  • Table 17 Global Spatial Omics Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 18 Global Spatial Omics Market Outlook, By Spatial Sequencing Systems (2023-2034) ($MN)
  • Table 19 Global Spatial Omics Market Outlook, By Spatial Imaging Systems (2023-2034) ($MN)
  • Table 20 Global Spatial Omics Market Outlook, By Microscopy Systems (2023-2034) ($MN)
  • Table 21 Global Spatial Omics Market Outlook, By Slide Scanners (2023-2034) ($MN)
  • Table 22 Global Spatial Omics Market Outlook, By Automated Sample Preparation Systems (2023-2034) ($MN)
  • Table 23 Global Spatial Omics Market Outlook, By Consumables & Reagents (2023-2034) ($MN)
  • Table 24 Global Spatial Omics Market Outlook, By Assay Kits (2023-2034) ($MN)
  • Table 25 Global Spatial Omics Market Outlook, By Reagents (2023-2034) ($MN)
  • Table 26 Global Spatial Omics Market Outlook, By Slides & Chips (2023-2034) ($MN)
  • Table 27 Global Spatial Omics Market Outlook, By Bar-coding & Labelling Kits (2023-2034) ($MN)
  • Table 28 Global Spatial Omics Market Outlook, By Antibodies & Probes (2023-2034) ($MN)
  • Table 29 Global Spatial Omics Market Outlook, By Sample Preparation Consumables (2023-2034) ($MN)
  • Table 30 Global Spatial Omics Market Outlook, By Software (2023-2034) ($MN)
  • Table 31 Global Spatial Omics Market Outlook, By Data Analysis Software (2023-2034) ($MN)
  • Table 32 Global Spatial Omics Market Outlook, By Image Analysis Software (2023-2034) ($MN)
  • Table 33 Global Spatial Omics Market Outlook, By Bioinformatics Platforms (2023-2034) ($MN)
  • Table 34 Global Spatial Omics Market Outlook, By Visualization Software (2023-2034) ($MN)
  • Table 35 Global Spatial Omics Market Outlook, By Cloud-Based Analytics Platforms (2023-2034) ($MN)
  • Table 36 Global Spatial Omics Market Outlook, By Services (2023-2034) ($MN)
  • Table 37 Global Spatial Omics Market Outlook, By Sample Processing Services (2023-2034) ($MN)
  • Table 38 Global Spatial Omics Market Outlook, By Sequencing Services (2023-2034) ($MN)
  • Table 39 Global Spatial Omics Market Outlook, By Imaging Services (2023-2034) ($MN)
  • Table 40 Global Spatial Omics Market Outlook, By Bioinformatics & Data Analysis Services (2023-2034) ($MN)
  • Table 41 Global Spatial Omics Market Outlook, By Consulting & Technical Support Services (2023-2034) ($MN)
  • Table 42 Global Spatial Omics Market Outlook, By Sample Type (2023-2034) ($MN)
  • Table 43 Global Spatial Omics Market Outlook, By Fresh Frozen Tissue (2023-2034) ($MN)
  • Table 44 Global Spatial Omics Market Outlook, By Formalin-Fixed Paraffin-Embedded Tissue (2023-2034) ($MN)
  • Table 45 Global Spatial Omics Market Outlook, By Cell Samples (2023-2034) ($MN)
  • Table 46 Global Spatial Omics Market Outlook, By Organoids (2023-2034) ($MN)
  • Table 47 Global Spatial Omics Market Outlook, By Tissue Microarrays (2023-2034) ($MN)
  • Table 48 Global Spatial Omics Market Outlook, By Others Sample Types (2023-2034) ($MN)
  • Table 49 Global Spatial Omics Market Outlook, By Software Deployment (2023-2034) ($MN)
  • Table 50 Global Spatial Omics Market Outlook, By On-Premises (2023-2034) ($MN)
  • Table 51 Global Spatial Omics Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 52 Global Spatial Omics Market Outlook, By Hybrid (2023-2034) ($MN)
  • Table 53 Global Spatial Omics Market Outlook, By Technology (2023-2034) ($MN)
  • Table 54 Global Spatial Omics Market Outlook, By Next-Generation Sequencing (2023-2034) ($MN)
  • Table 55 Global Spatial Omics Market Outlook, By In Situ Hybridization (2023-2034) ($MN)
  • Table 56 Global Spatial Omics Market Outlook, By Fluorescence Imaging (2023-2034) ($MN)
  • Table 57 Global Spatial Omics Market Outlook, By Imaging Mass Spectrometry (2023-2034) ($MN)
  • Table 58 Global Spatial Omics Market Outlook, By Digital Spatial Profiling (2023-2034) ($MN)
  • Table 59 Global Spatial Omics Market Outlook, By Application (2023-2034) ($MN)
  • Table 60 Global Spatial Omics Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 61 Global Spatial Omics Market Outlook, By Neuroscience (2023-2034) ($MN)
  • Table 62 Global Spatial Omics Market Outlook, By Immunology (2023-2034) ($MN)
  • Table 63 Global Spatial Omics Market Outlook, By Developmental Biology (2023-2034) ($MN)
  • Table 64 Global Spatial Omics Market Outlook, By Cell Biology (2023-2034) ($MN)
  • Table 65 Global Spatial Omics Market Outlook, By Cardiovascular Research (2023-2034) ($MN)
  • Table 66 Global Spatial Omics Market Outlook, By Infectious Disease Research (2023-2034) ($MN)
  • Table 67 Global Spatial Omics Market Outlook, By Regenerative Medicine (2023-2034) ($MN)
  • Table 68 Global Spatial Omics Market Outlook, By Biomarker Discovery (2023-2034) ($MN)
  • Table 69 Global Spatial Omics Market Outlook, By Drug Discovery & Development (2023-2034) ($MN)
  • Table 70 Global Spatial Omics Market Outlook, By Precision Medicine (2023-2034) ($MN)
  • Table 71 Global Spatial Omics Market Outlook, By Clinical Diagnostics (2023-2034) ($MN)
  • Table 72 Global Spatial Omics Market Outlook, By End User (2023-2034) ($MN)
  • Table 73 Global Spatial Omics Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 74 Global Spatial Omics Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 75 Global Spatial Omics Market Outlook, By Hospitals & Clinical Laboratories (2023-2034) ($MN)
  • Table 76 Global Spatial Omics Market Outlook, By Contract Research Organizations (2023-2034) ($MN)
  • Table 77 Global Spatial Omics Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 78 Global Spatial Omics Market Outlook, By Government & Public Health Organizations (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.